Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/1991
03/21/1991WO1991003254A1 Wound healing
03/21/1991WO1991003234A1 Drug containing matrix
03/21/1991CA2025744A1 13-bromo-and 13,14-dibromoergolines, their production and use in medicinal agents
03/20/1991EP0418143A1 Dicarboxylic acids derivatives containing a nitrogen or oxygen heteroring, process for their preparation and their use as medicines
03/20/1991EP0418071A2 New N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase
03/20/1991EP0418004A2 Preventive and therapeutic agent for hepatitis
03/20/1991EP0417818A1 Selecting amounts of platelet releasate for efficacious treatment of tissue
03/20/1991EP0417760A2 Phenylalkanoyl substituted imidazo[4,5-c] pyridines
03/20/1991EP0417751A2 New thiazole derivatives, processes for the preparation thereof and pharmaceutical compositon comprising the same
03/20/1991EP0417745A2 Heteroaryl substituted imidazo [4,5-c] pyridines
03/20/1991EP0417725A2 Bile-acid derivatives, a process for their production and their use as medicines
03/20/1991EP0417721A2 Novel peptidase and isomerase inhibitors
03/20/1991EP0417473A1 Treatment of cardiac and also vascular hypertrophy and hyperplasia
03/20/1991CA2025471A1 Additional further novel aklanophenones
03/19/1991US5001241 3-KETO HMG-CoA reductase inhibitors
03/19/1991US5001236 Benzothiazepines
03/19/1991US5001222 Des-17-histidine-calcitonin
03/19/1991US5001148 Mevinic acid derivatives
03/19/1991US5001135 Indole derivatives
03/19/1991US5001057 Truncated human IL-1 cDNA sequences which encode biologically-active human IL-1 proteins
03/19/1991CA2023763A1 Isoprenoid phosphinylformic acid squalene synthetase inhibitors and method
03/19/1991CA1281650C Aqueous preparation containing cyclodextrin
03/19/1991CA1281648C Remedy for bone disease containing organogermanium compound
03/16/1991WO1991004035A1 Selecting amounts of platelet releasate for efficacious treatment of tissue
03/16/1991CA2066588A1 Selecting amounts of platelet releasate for efficacious treatment of tissue
03/16/1991CA2025356A1 Thiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
03/16/1991CA2023936A1 Diol sulfonamide and sulfinyl renin inhibitors
03/14/1991CA2025202A1 Phenylalkanoyl substituted imidazo {4,5-c} pyridines
03/14/1991CA2025084A1 Heteroaryl substituted imidazo [4,5-c] pyridines
03/13/1991EP0417060A2 Bicyclic tetrahydroxypyrrolizidine
03/13/1991EP0416689A2 Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors
03/13/1991EP0416652A2 Interferon-gamma receptor fragment and its production
03/13/1991EP0416609A2 Benzo[b]thiophene-containing lipoxygenase-inhibiting compounds
03/13/1991EP0416578A2 Protein, DNA and use thereof
03/13/1991EP0416527A2 Prostaglandin-containing liposome preparations
03/13/1991EP0416393A1 Peptidyl difluorodiol renin inhibitors
03/13/1991EP0416383A2 Substituted aminopyridines
03/13/1991EP0416373A2 Amino acid derivatives
03/13/1991EP0416069A1 New leucotriene b 4 derivatives, a method of preparing them, and their use as drugs.
03/13/1991EP0416034A1 Penetration enhancers for transdermal delivery of systemic agent
03/13/1991EP0416029A1 Procalcitonin peptides
03/13/1991EP0415981A1 Retroviral protease inhibitors
03/13/1991EP0415924A1 Regulation of cell proliferation and differentiation using peptides.
03/13/1991CA2025036A1 Dicarboxylic derivatives comprizing a nitrogenous or oxygenous heterocycle, process for their preparation and use as medicaments
03/12/1991WO1991004267A1 A method for the purification of transforming growth factor (tgf-)
03/12/1991US4999435 Cationic Surfactants, Drugs, Immunoassay
03/12/1991US4999382 Compositions for treating tobacco withdrawal symptoms and methods for their use
03/12/1991US4999364 Aromatase inhibitors; fungicides, plant growth regulators, and anticarcinogenic agents
03/12/1991US4999363 Tricyclic compounds
03/12/1991US4999355 Antiserotonine agents
03/12/1991CA2066576A1 Method and apparatus for the production of tgf-beta and purified tgf-beta compositions
03/12/1991CA2024965A1 Preventive and therapeutic agent for hepatitis
03/12/1991CA2024661A1 Peptidase and isomerase inhibitors
03/12/1991CA1281331C Thio-substituted aromatic alcohols
03/12/1991CA1281330C2 Intermediates for the preparation of n-alkylated dipeptides and their esters
03/12/1991CA1281329C Lipoxygenase inhibitors
03/12/1991CA1281324C Lipid derivatives, their production and use
03/09/1991WO1991003475A1 Substituted urea compounds and their preparation and use
03/09/1991CA2066696A1 Substituted urea compounds and their preparation and use
03/09/1991CA2024841A1 Bicyclic tetrahydroxypyrrolizidine
03/08/1991CA2024804A1 Prostaglandin-containing liposome preparations
03/07/1991WO1991003099A1 Compressed powder medicaments
03/07/1991WO1991002796A1 Cystic fibrosis gene
03/07/1991WO1991002788A1 Herpes simplex virus type 1 mutant
03/07/1991WO1991002540A1 Compositions for the inhibition of protein hormone formation and uses thereof
03/07/1991WO1991002537A1 Synthetic peptides that enhance cell binding
03/07/1991WO1991001123A3 Quinolinyl-benzopyran derivatives as antagonists of leukotriene d¿4?
03/07/1991CA2024576A1 Hmg-coa reductase-inhibiting substituted amino-pyridines
03/06/1991EP0415886A2 Aza compounds
03/06/1991EP0415850A1 Bivalent metal salts of 2-N,N-di(carboxymethyl)amino,3-cyano,4-carboxymethyl,5-carboxy-thiophene-acid, process for their preparation and pharmaceutical compositions containing them
03/06/1991EP0415693A1 Composition and method for selective enhancement of opiate activity and reduction of opiate tolerance and dependence
03/06/1991EP0415623A2 Toremifene or demethyltoremifene as hydroxytoremifene for the reversal of multidrug restistance of cancer cells against cytotoxic drugs
03/06/1991EP0415566A1 Heterocyclic compounds, processes for producing them and pharmaceutical compositions comprising them
03/06/1991EP0415488A2 7-Substituted HMG-COA reductase inhibitors
03/06/1991EP0415321A1 Oligodendrocyte cytotoxic factor
03/06/1991EP0414903A1 New thioproline derivative
03/06/1991EP0190356B1 Novel amidine compounds
03/06/1991CN1049663A Pyrroloquinoline compounds
03/06/1991CN1049657A Disubstituted(quinolin-2-yl-methoxy) phenylacetic acid derivatives
03/06/1991CA2024698A1 Peptidyl diflurodiol renin inhibitors
03/05/1991US4997850 Alcohol or ester
03/05/1991US4997844 Compounds for the treatment of allergic or inflammatory diseases or shock conditions
03/05/1991US4997841 Indole derivatives
03/05/1991US4997839 2-quinolyl ethers
03/05/1991US4997831 Lactam derivatives
03/05/1991US4997824 Bone disorders
03/05/1991US4997658 Method for enhancing the lowering of plasma cholesterol levels
03/05/1991US4997645 Administering interferon and dipyridamole
03/05/1991CA2023099A1 Amino acid derivatives
03/01/1991WO1991003466A1 Substituted quinolines
03/01/1991CA2064015A1 Substituted quinolines
03/01/1991CA2024248A1 7-substituted hmg-coa reductase inhibitors
03/01/1991CA2024137A1 Aza compounds
03/01/1991CA2024030A1 Oligodendrocyte cytotoxic factor
02/1991
02/27/1991EP0414530A2 3-Nitro-substituted steroid derivatives
02/27/1991EP0414529A2 7-Keto- and 7-Hydroxy-androsta-3,5-diene-3-carboxylic acid derivatives
02/27/1991EP0414490A2 17 Beta-acyl-4-aza-5 alpha-androst-1-ene-3-one as 5 alpha-reductase inhibitors
02/27/1991EP0414206A2 2,4,6-Substituted phenol derivatives
02/27/1991EP0414190A2 Phosphonate substituted amino or imino acids useful as antihypertensives
02/27/1991EP0414175A2 Use of xanthine derivatives to reduce nephrotoxicity
1 ... 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 ... 1564